Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA…
Article ContentProstate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved drug and 30 in development. Quantitative PSMA-PET imaging is required to determine patient…